Search Results 2481-2490 of 21950 for platelets

1. Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine - Mayo Clinic

   At least one cytopenia (Absolute Neutrophil Count (ANC) < 1800/μL or Platelet (PLT) count < 100,000/μL or hemoglobin (Hgb) < 10 g/dL). Progression ...

2. A Study to Evaluate the Effectiveness and Safety of rAd-IFN Administered With Celecoxib and Gemcitabine in Patients With Malignant Pleural Mesothelioma - Mayo Clinic

   Platelet count 100,000/µL;; International normalized ratio (INR) and activated partial thromboplastin time (aPTT) below the upper limit of normal (ULN). It ...

3. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

   Platelets ≥ 100,000/mm^3;; Hemoglobin ≥ 9 g/dL;; Bilirubin ≤ 1.5 x the ULN. For subjects with known Gilbert's disease, bilirubin ≤ 3.0 x ULN;; Serum ...

4. Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery - Mayo Clinic

   Platelets ≥ 100,000/mcL; Total bilirubin ≤ 1.5 X institutional upper limit of normal; Aspartate aminotransferase (AST) (serum glutamic oxaloacetic ...

5. A Study of Poziotinib in Patients with NSCLC With EGFR or HER2 Exon 20 Insertion Mutation - Mayo Clinic

   Platelet count ≥ 100×10^9/L;; Hemoglobin ≥ 9.0 g/dL;; Total bilirubin ≤ 2 mg/dL; if hepatic metastases are present, ≤ 2.5 × ULN;; SGOT (AST) and SGPT (ALT) ...

6. Veliparib and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer - Mayo Clinic

   Platelet count must be >= 100,000/mm^3; Hemoglobin must be >= 10 g/dL; Total bilirubin must be =< ULN (upper limit of normal) for the lab unless the patient ...

7. Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer - Mayo Clinic

   Platelets (PLT) ≥ 100,000/mm^3; Total bilirubin ≤ 1.5 x upper normal limit (UNL); Aspartate aminotransferase (AST) ≤ 2.0 x UNL; Left ventricular ejection ...

8. Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer - Mayo Clinic

   Platelet count >= 75,000/mm^3; Creatinine =< 1.5 x upper limits of normal (ULN); Total bilirubin =< 1.5 x upper limits of normal (ULN); Aspartate ...

9. S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma - Mayo Clinic

   Platelets >= 50,000 cells/mm^3 for patients who have bone marrow plasmacytosis < 50% or >= 30,000 cells/mm^3 for patients who have bone marrow plasmacytosis ...

10. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

    Platelets ≥ 100,000/μL (without transfusion support within 28 days prior to randomization); Hemoglobin ≥ 9.0 g/dL (without transfusion support within 14 ...